While Cardlytics Inc has overperformed by 2.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CDLX rose by 189.46%, with highs and lows ranging from $20.52 to $4.70, whereas the simple moving average jumped by 34.02% in the last 200 days.
On March 15, 2024, Craig Hallum Upgraded Cardlytics Inc (NASDAQ: CDLX) to Buy. A report published by Lake Street on November 29, 2023, Initiated its previous ‘Buy’ rating for CDLX. Wells Fargo also Downgraded CDLX shares as ‘Underweight’, setting a target price of $13 on the company’s shares in a report dated September 08, 2022. Wells Fargo July 14, 2022d the rating to Equal Weight on July 14, 2022, and set its price target from $72 to $15. BofA Securities July 13, 2022d its ‘Neutral’ rating to ‘Underperform’ for CDLX, as published in its report on July 13, 2022. Craig Hallum’s report from July 12, 2022 suggests a price prediction of $20 for CDLX shares, giving the stock a ‘Hold’ rating. Wells Fargo also rated the stock as ‘Overweight’.
Analysis of Cardlytics Inc (CDLX)
Further, the quarter-over-quarter increase in sales is 8.08%, showing a positive trend in the upcoming months.
Cardlytics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -77.77% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.31, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and CDLX has an average volume of 1.71M. On a monthly basis, the volatility of the stock is set at 11.73%, whereas on a weekly basis, it is put at 6.80%, with a loss of -3.11% over the past seven days. Furthermore, long-term investors anticipate a median target price of $17.00, showing growth from the present price of $14.01, which can serve as yet another indication of whether CDLX is worth investing in or should be passed over.
How Do You Analyze Cardlytics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.68%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 68.14% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CDLX shares are owned by institutional investors to the tune of 68.14% at present.
